Current methods and approaches for viral clearance

Protecting biotech products from viral contamination

Webinar | 30th May 2024 2pm - 3pm (BST)

 

Join microbiology and sterility expert Dr Tim Sandle and RSSL's Biologics commercial lead Gaynor Johnston for a critical look at the dangers of viral contamination in biological and biotechnological products and how viral clearance can garner greater confidence than product testing alone.

 

Viruses present a difficult contamination challenge for vaccine manufacturers. Complete viral safety, as defined by absolute freedom from extraneous viral agents, is not easy to achieve and some would argue that it is an impossible task due to the difficulties in testing for the full range of pathogenic viruses and residual pathogenicity. 

 

Therefore, whilst product testing can support control measures in terms of the showing that the probability of viral contamination is low, greater confidence is garnered through viral clearance strategies and associated risk assessment. This webinar aims to assess the key factors for viral clearance and examine the current methods used to remove viral particles from the product stream.

Book your place on this insightful webinar today

Contact us

Need to get in touch? Either complete the enquiry form or call us:

Switchboard: +44 (0)118 918 4000

Customer Services: +44 (0)118 918 4076

We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.

;